EPO and chronic kidney disease: Lastly, both CKD and HF are frequently associated with anemia due to erythropoietin impairment, uremia-induced inhibitors of erythropoiesis, reduced erythrocyte survival, and pathologic iron homeostasis [33], resulting in neurohormonal overactivity and thus further deterioration of renal and cardiac function [34].